Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 1/20 | 0.36 |
| ▸ | CCR2 | P41597 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | P2RX7 | Q99572 | 4/20 | 0.33 |
| ▸ | PTGDR2 | Q9Y5Y4 | 2/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 3/20 | 0.32 |
| ▸ | MYC | P01106 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6490479 | 0.91 | CCR1 (0.36) | CCR1CCR2MAPK1P2RX7PTGDR2 | |
| SCHEMBL6480890 | 0.88 | CCR1 (0.36) | CCR1CCR2MAPK1P2RX7CYP1A2 | |
| SCHEMBL6492570 | 0.85 | KMT2A (0.37) | MAPK1CYP1A2CYP2C9HPGDCYP2C19 | |
| SCHEMBL6494834 | 0.84 | P2RX7 (0.42) | CCR1CCR2MAPK1P2RX7CYP1A2 | |
| SCHEMBL6478972 | 0.79 | MAPK1 (0.33) | MAPK1CYP1A2CYP2C9HPGDCYP2C19 | |
| SCHEMBL20010404 | 0.79 | PTGDR2 (0.44) | PTGDR2 | |
| SCHEMBL22317847 | 0.79 | MAPT (0.46) | LMNA | |
| SCHEMBL6492930 | 0.79 | ENPP2 (0.38) | PTGDR2LMNAMYC | |
| SCHEMBL5184240 | 0.78 | ALDH1A1 (0.44) | CYP1A2CYP2C9HPGDCYP2C19 | |
| SCHEMBL6480246 | 0.78 | ALDH1A1 (0.34) | MAPK1CYP1A2CYP2C9HPGDCYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050090398-A1 | Novel tetrazole derivative useful as herbicides | YANAGI AKIHIKO (JP) | 2005-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050090398-A1 | Novel tetrazole derivative useful as herbicides | DDT, TTI1, CYP1A1 | CCR1 1965/4885CCR2 1872/4885MAPK1 2914/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.